DIARECT AG of Freiburg at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine

DIARECT AG

Bötzinger Str. 29B, 79111 Freiburg
Germany
Telephone +49 761 479790
Fax +49 761 4797929
info@diarect.com

This company is main exhibitor of

Hall map

MEDICA 2019 hall map (Hall 1): stand D37

Fairground map

MEDICA 2019 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing
  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.02  Microbiological diagnosis, virology, equipment and systems for

Microbiological diagnosis, virology, equipment and systems for

Our products

Product category: Immuno assay testing

BioFX® TMB One Component

Intended use:

The BioFX® TMB family has a broad range of kinetic rates with low background and improved signal-to-noise ratios that improve assay performance.

The BioFX TMB One Component HRP Microwell Substrate contains 3,3’,5,5’-tetramethylbenzidine (TMB) and is supplied as a ready-to-use solution. Peroxidase reacts with the substrate solution to produce a soluble blue reaction product that can be read at 370 nm or 620-650 nm for ELISA applications. Stop solutions can be added to prevent further color development and reading the absorbance values at the desired wavelengths.

A soluble yellow product develops after stopping and stabilizing with a 450 nm stop solution.

The developing soluble blue product can be stopped and stabilized by using a 650 nm stop solution.

More Less

Product category: Immuno assay testing

BioFX® TMB Double Slow One Component

Intended use:

The BioFX® TMB family has a broad range of kinetic rates with low background and improved signal-to-noise ratios that improve assay performance. The BioFX TMB Double Slow One Component HRP Microwell Substrate contains 3,3’,5,5’-tramethylbenzidine
(TMB) and is supplied as a ready-to-use solution. Peroxidase reacts with the substrate solution to produce a soluble blue reaction product that can be read at 370 nm or 620-650 nm for ELISA applications. Stop solutions can be added to prevent further color development and reading the absorbance values at the desired wavelengths.

A soluble yellow product develops after stopping and stabilizing with a 450 nm stop solution.

The developing soluble blue product can be stopped and stabilized by using a 650 nm stop solution.

More Less

Product category: Immuno assay testing

BioFX® TMB Enhanced One Component

Intended use:

BioFX® TMB Enhanced One Component HRP Membrane Substrate is a ready-to-use solution containing 3,3’,5,5’-tetramethylbenzidine in a mildly acidic buffer. The substrate reacts with peroxidase to form an insoluble permanent dark blue/purple color on the membrane or surface to which it is applied.
This enhanced formulation extends the dynamic range of detection, especially at higher concentrations of peroxidase where other substrates may exhibit loss of signal due to washout effects. Unreacted substrate should be fain t yellow to pink in appearance.

More Less

About us

Company details

The Quality League of Immunodiagnostic Components
DIARECT AG is a privately owned biotech company with over 20 years expertise in developing and establishing standardized large-scale productions of both recombinant and native proteins, including their worldwide distribution. Providing customers with products and services of consistent quality is the cornerstone of DIARECT’s business philosophy.

DIARECT is not only a leading manufacturer of autoimmune and infectious disease antigens, but also of recombinant allergens. The most recent additions to the product portfolio were human chimeric antibodies and modified autoimmune disease antigens. In addition, DIARECT is the exclusive distributor of Surmodics in Europe. With Surmodics' protein stabilization reagents, blockers and BioFX substrates, DIARECT is able to provide the critical components for the development of diagnostic end products.

Research & Development
Since its founding, DIARECT has been involved in numerous product innovations:

First thyroid peroxidase antibody test system, based on recombinant TPO
First ANA/ENA profile and screening assay, utilizing several recombinant proteins
Most complete panel of recombinant tick-borne disease antigens
Introduction of symmetrically dimethylated recombinant SmD proteins
Supply of antigens for the detection of rare antibodies, e.g. EJ, KS, MDA5, TIF1 gamma
Development of purified native and recombinant allergens for component-resolved diagnostics
Supply of biotinylated autoimmune disease antigens
Large-scale production of human chimeric autoantibodies
 

Driven by the commitment to further expand its range of products, DIARECT will continue the development of new and innovative products in the years to come.

Manufacturing Experience
With more than 20 years of experience in the development and production of antigens as well as the corresponding customer tech support, DIARECT has recognized that test performances are directly dependent on a sophisticated assay development process and high-quality components. In order to minimize variances during manufacturing processes, all components need to be available in sufficient amounts of reproducible quality. The production of large lot sizes with high lot-to-lot consistency is DIARECT’s expertise.

Innovation
Innovation is the creative result of basic and applied research. In order to generate superior product performance, DIARECT endeavors to combine intensive, first-class research experience with formative years of practical experience in immunodiagnostic manufacturing.

Committed to Clinical Science
Aiming to enhance assay performance, DIARECT provides superior components for exceptional assay quality. This concept includes the support of researchers and worldwide scientific collaborations.

More Less